Imagion Biosystems Ltd
ASX:IBX
Imagion Biosystems Ltd
ASX:IBX
Price:
0.022
AUD
-4.35%
Market Cap:
AU$10.8m
Income Statement
Earnings Waterfall
Imagion Biosystems Ltd
Imagion Biosystems Ltd
Income Statement
Imagion Biosystems Ltd
Imagion Biosystems Ltd
Currency: AUD
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
|
| Revenue |
0
N/A
|
0
+13%
|
0
+3%
|
0
-42%
|
1
+101%
|
1
+10%
|
0
-56%
|
0
+40%
|
1
+67%
|
1
+74%
|
1
+45%
|
2
+35%
|
1
-40%
|
1
-10%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(9)
|
(8)
|
(6)
|
(7)
|
(8)
|
(8)
|
(9)
|
(11)
|
(13)
|
(15)
|
(17)
|
(11)
|
(3)
|
(2)
|
|
| Selling, General & Administrative |
(6)
|
(3)
|
(3)
|
(3)
|
(5)
|
(6)
|
(6)
|
(6)
|
(8)
|
(9)
|
(10)
|
(7)
|
(3)
|
(1)
|
|
| Research & Development |
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(3)
|
(0)
|
(1)
|
|
| Depreciation & Amortization |
(0)
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
(2)
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(9)
N/A
|
(8)
+13%
|
(5)
+28%
|
(6)
-17%
|
(7)
-17%
|
(8)
-2%
|
(9)
-14%
|
(10)
-19%
|
(12)
-18%
|
(14)
-13%
|
(15)
-12%
|
(9)
+38%
|
(2)
+77%
|
(1)
+55%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Other Income |
0
|
2
|
2
|
2
|
2
|
3
|
3
|
0
|
3
|
3
|
4
|
4
|
0
|
0
|
|
| Pre-Tax Income |
(8)
N/A
|
(5)
+39%
|
(3)
+33%
|
(4)
-22%
|
(5)
-28%
|
(5)
+5%
|
(6)
-19%
|
(10)
-72%
|
(10)
+5%
|
(12)
-20%
|
(12)
-6%
|
(6)
+49%
|
(2)
+67%
|
(2)
-7%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(8)
|
(5)
|
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
(10)
|
(10)
|
(12)
|
(12)
|
(6)
|
(2)
|
(2)
|
|
| Net Income (Common) |
(8)
N/A
|
(5)
+39%
|
(3)
+33%
|
(4)
-22%
|
(5)
-28%
|
(5)
+5%
|
(6)
-19%
|
(10)
-72%
|
(10)
+5%
|
(12)
-20%
|
(12)
-6%
|
(6)
+49%
|
(2)
+67%
|
(2)
-7%
|
|
| EPS (Diluted) |
-0.04
N/A
|
-0.02
+50%
|
-0.01
+50%
|
-0.01
N/A
|
-0.29
-2 800%
|
-0.01
+97%
|
-0.23
-2 200%
|
-0.36
-57%
|
-0.35
+3%
|
-0.41
-17%
|
-0.41
N/A
|
-0.2
+51%
|
-0.05
+75%
|
-0.02
+60%
|
|
Switch to:
Switch to:
See Also
Discover More
